Observational studyMedicina (Kaunas, Lithuania)2026
Real-World Experience with Nintedanib in a Progressive Pulmonary Fibrosis Cohort.
Vanesa Vicens-Zygmunt, Jaume Bordas-Martínez, Miriam Muñoz-Bolaño, João Carmezim, Ana Belén Llanos-González, Adrià Domingo-Carnice, Dolores Rodríguez-Cumplido, Guadalupe Bermudo-Peloche, Cristian Tebé-Cordomí, Judith Peñafiel and 2 more
Abstract readObservational Study
In one paragraphObservational study in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Vanesa Vicens-ZygmuntInterstitial Lung Disease (ILD) Unit, Pulmonology Department, University Hospital of Bellvitge, Institute of Research of Bellvitge (DIBELL), University of Barcelona (UB), Biomedical Research Network Center Respiratory Diseases (CIBERES), 08907 Barcelona, Spain.ORCID 0000-0002-0940-3215 Jaume Bordas-MartínezInterstitial Lung Disease (ILD) Unit, Pulmonology Department, University Hospital of Bellvitge, Institute of Research of Bellvitge (DIBELL), University of Barcelona (UB), Biomedical Research Network Center Respiratory Diseases (CIBERES), 08907 Barcelona, Spain.ORCID 0000-0003-4027-8907 João CarmezimBiostatistics Unit (UBiDi), Bellvitge Biomedical Research Institute (IDIBELL), 08840 Barcelona, Spain.
Ana Belén Llanos-GonzálezInterstitial Lung Disease Unit, Pulmonology Department, University Complex Hospital of Canarias, 38320 Santa Cruz de Tenerife, Spain.ORCID 0000-0002-0467-4024 Adrià Domingo-CarniceClinical Pharmacology Department, University Hospital of Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0001-8736-0671 Dolores Rodríguez-CumplidoClinical Pharmacology Department, University Hospital of Bellvitge, 08907 Barcelona, Spain.
Guadalupe Bermudo-PelocheInterstitial Lung Disease (ILD) Unit, Pulmonology Department, University Hospital of Bellvitge, Institute of Research of Bellvitge (DIBELL), University of Barcelona (UB), Biomedical Research Network Center Respiratory Diseases (CIBERES), 08907 Barcelona, Spain.ORCID 0000-0002-2010-7679 Cristian Tebé-CordomíBiostatistics Unit (UBiDi), Bellvitge Biomedical Research Institute (IDIBELL), 08840 Barcelona, Spain.
Judith PeñafielBiostatistics Unit (UBiDi), Bellvitge Biomedical Research Institute (IDIBELL), 08840 Barcelona, Spain.
Roser Llop-RiusClinical Pharmacology Department, University Hospital of Bellvitge, 08907 Barcelona, Spain.
Maria Molina-MolinaInterstitial Lung Disease (ILD) Unit, Pulmonology Department, University Hospital of Bellvitge, Institute of Research of Bellvitge (DIBELL), University of Barcelona (UB), Biomedical Research Network Center Respiratory Diseases (CIBERES), 08907 Barcelona, Spain.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
IndolesPulmonary FibrosisAgedCohort StudiesDisease ProgressionFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeVital CapacityIndolesnintedanibantifibroticcohortimmunosuppressantspulmonary fibrosispulmonary function testsreal-world
Identifiers
PMID42356199
PMCPMC13303150
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390